Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Pheromone Technologies is a biotechnology company specializing in the development of semiochemical-based solutions for pest management. The company's primary focus is the commercialization of a highly effective pheromone lure for bed bugs (Cimex lectularius), which was developed through extensive research at Simon Fraser University. This technology utilizes a specific blend of synthetic pheromones to attract bed bugs, providing a non-toxic and efficient method for detecting and monitoring infestations. By leveraging the natural chemical communication of insects, the company offers an alternative to traditional broad-spectrum insecticides. Their products are designed for use in residential, commercial, and hospitality settings to improve public health and sanitation. The company continues to explore the application of pheromone technology for other urban and agricultural pests.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Pheromone Technologies.